ZTS | Zoetis

161.49 -5.00 (-3.00%)

ZTS Price Profile

Open

$164.12

CLOSE

$161.49

DAY RANGE

161.42 - 165.18

52 WEEK RANGE

156.67 - 249.27

MARKET CAP

89.82B

Trading volume

1.61M

Prev. Close

166.49

50 Day MA

223.36

Shares Outstanding

473.13M

Public Float

472.41M

Average Volume

2.84M

Beta

0.66

PEG Ratio

3.27

Shares Shorted

2.02M

% OF SHARES SHORTED

0.43%

Short Ratio

1.35

1 Year Performance

24.74%

Diluted EPS (TTM)

4.15

Q Revenue Growth

0.11

Ebitda

3.14B

Gross Profit (TTM)

4.64B

Total Cash (MRQ)

3.3B

Total Debt (MRQ)

6.76B

  • MRQ = Most Recent Quarter.
  • TTM = Trailing Twelve Months.

Zoetis (ZTS) company profile

Zoetis Inc. (NYSE: ZTS) is an American company that discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products with customers globally. The company also offers pharmaceutical products, including pain and sedation, antiemetic, reproductive, and oncology products. The company’s business focuses on commercializing products across eight key species: dogs, cats, horses, cattle, swine, poultry, fish, and sheep.

Latest ZTS News

AD